Tirzepatide is the active molecule sold as Zepbound for weight loss and Mounjaro for type 2 diabetes the rashes and injection-site reactions described here apply to all three brand names
Week 14 involves 0.25 mg weekly injections, establishing baseline tolerance
Those with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should avoid it
Nielsen R, Moller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, Harms HJ, Frokiaer J, Eiskjaer H, Jespersen NR, et al
Risk of dipeptidyl peptidase-4 (DPP-4) inhibitors on site-specific cancer: A systematic review and meta-analysis
Leaves skin smoother and brighter The Exfoliating Body Scrub uses both chemical exfoliation and mineral-based polishing